机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[3]Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.[4]Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[5]Lymphoma Project Group, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院
Sichuan Science
and Technology Department for Key Research and
Development projects (2019YFS0027).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
通讯作者:
通讯机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.[2]Department of Oncology, West China Hospital, Sichuan University, Chengdu, China.[4]Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.[*1]Department of Hematology, West China Hospital of Sichuan University. No. 37, Guoxue Xiang, Wuhou District, Chengdu 610041, China.[*2]Department of Oncology, West China Hospital of Sichuan University. No. 37, Guoxue Xiang, Wuhou District, Chengdu 610041, China.
推荐引用方式(GB/T 7714):
Chunli Yang,Ming Jiang,Ziyan Ma,et al.Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020[J].Cancer medicine.2022,doi:10.1002/cam4.5136.
APA:
Chunli Yang,Ming Jiang,Ziyan Ma,Jie Ji,Shuli Lv...&Liqun Zou.(2022).Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020.Cancer medicine,,
MLA:
Chunli Yang,et al."Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020".Cancer medicine .(2022)